These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21633294)

  • 21. Attitudes on warfarin pharmacogenetic testing in Chinese patients and public.
    Chan SL; Low JJ; Chia KS; Wee HL
    Int J Technol Assess Health Care; 2014 Jan; 30(1):113-20. PubMed ID: 24468050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK.
    Sanderson SC; Wardle J; Jarvis MJ; Humphries SE
    Prev Med; 2004 Sep; 39(3):458-64. PubMed ID: 15313084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
    Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
    Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes of health care professionals toward pharmacogenetic testing.
    Zgheib NK; Arawi T; Mahfouz RA; Sabra R
    Mol Diagn Ther; 2011 Apr; 15(2):115-22. PubMed ID: 21623646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Public Trust and Provider Specialty Among Physicians With Financial Conflicts of Interest.
    Niforatos JD; Chaitoff A; Mercer MB; Yu PC; Rose SL
    Mayo Clin Proc; 2019 Dec; 94(12):2467-2475. PubMed ID: 31806100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicians' Attitudes and Ethical Obligations to Pharmacogenetic Testing.
    Muflih S; Al-Husein BA; Karasneh R; Alzoubi KH
    J Multidiscip Healthc; 2020; 13():249-258. PubMed ID: 32210569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research.
    Daud ANA; Bergsma EL; Bergman JEH; De Walle HEK; Kerstjens-Frederikse WS; Bijker BJ; Hak E; Wilffert B
    BMC Pregnancy Childbirth; 2017 Apr; 17(1):120. PubMed ID: 28410576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved.
    Gawronski BE; Cicali EJ; McDonough CW; Cottler LB; Duarte JD
    Front Genet; 2022; 13():1085994. PubMed ID: 36712853
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacogenetic testing, informed consent and the problem of secondary information.
    Netzer C; Biller-Andorno N
    Bioethics; 2004 Aug; 18(4):344-60. PubMed ID: 15449406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential of a placebo/nocebo effect in pharmacogenetics.
    Haga SB; Warner LR; O'Daniel J
    Public Health Genomics; 2009; 12(3):158-62. PubMed ID: 19204418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Attitudes of Physicians and the General Public toward Prognostic Disclosure of Different Serious Illnesses: a Korean Nationwide Study.
    Oh SN; Kim YA; Kim YJ; Shim HJ; Song EK; Kang JH; Kwon JH; Lee JL; Lee SN; Maeng CH; Kang EJ; Do YR; Yun HJ; Jung KH; Yun YH
    J Korean Med Sci; 2020 Dec; 35(47):e401. PubMed ID: 33289368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public attitudes in Japan toward participation in whole genome sequencing studies.
    Okita T; Ohashi N; Kabata D; Shintani A; Kato K
    Hum Genomics; 2018 Apr; 12(1):21. PubMed ID: 29653595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social networkers' attitudes toward direct-to-consumer personal genome testing.
    McGuire AL; Diaz CM; Wang T; Hilsenbeck SG
    Am J Bioeth; 2009; 9(6-7):3-10. PubMed ID: 19998099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicians' attitudes toward pharmacogenetic testing before and after pharmacogenetic education.
    Luzum JA; Luzum MJ
    Per Med; 2016 Mar; 13(2):119-127. PubMed ID: 29749904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disclosure of cancer diagnosis and prognosis: a survey of the general public's attitudes toward doctors and family holding discretionary powers.
    Miyata H; Tachimori H; Takahashi M; Saito T; Kai I
    BMC Med Ethics; 2004 Dec; 5():E7. PubMed ID: 15571636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of physician opinions in Russia in the field of pharmacogenetics of cardiovascular disease.
    Sychev D; Fedina L; Poptsova M; Zateyshchikov D; Mirzaev K; Tsimbal E; Sychev I; Rastvorova T
    Pharmacogenomics; 2022 Oct; 23(15):847-856. PubMed ID: 36093937
    [No Abstract]   [Full Text] [Related]  

  • 38. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.
    Albassam A; Alshammari S; Ouda G; Koshy S; Awad A
    PLoS One; 2018; 13(9):e0203033. PubMed ID: 30183746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 40. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation.
    Deininger KM; Tsunoda SM; Hirsch JD; Anderson H; Lee YM; McIlvennan CK; Page RL; Tran JN; Aquilante CL
    Clin Transplant; 2020 Oct; 34(10):e14037. PubMed ID: 32654213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.